Kyorin Holdings Inc (4569)

Tokyo
Currency in JPY
1,596.0
-4.0(-0.25%)
Closed
4569 Scorecard
Full Analysis
Prominent player in the Pharmaceuticals industry
Fair Value
Day's Range
1,595.01,607.0
52 wk Range
1,331.01,880.0
Kyorin Holdings Inc is currently considered to be trading at Fair valueExplore our list of undervalued stocks for hidden opportunities
Key Statistics
Edit
Bid/Ask
1,595.00 / 1,600.00
Prev. Close
1,600
Open
1,603
Day's Range
1,595-1,607
52 wk Range
1,331-1,880
Volume
66.2K
Average Volume (3m)
136.1K
1-Year Change
-10.94%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4569 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
1,300.0
Downside
-18.55%
Members' Sentiments
Bearish
Bullish
ProTips
Stock price often moves in the opposite direction of the market
No news in this category
Looks like there are no results in this news category

Kyorin Holdings Inc Company Profile

KYORIN Pharmaceutical Co., Ltd., through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally. The company offers Flutiform, a drug for the treatment of asthma; Lyfuna for cough treatment; Desalex, an antiallergic agent; Beova, Uritos, and Imidafenacin KYORIN therapeutic agents for overactive bladder; Lasvic, a quinolone synthetic antibacterial agent; Pentasa, a remedy for ulcerative colitis/Crohn's disease; Nasonex and Mometasone KYORIN, which are used as allergic rhinitis therapeutic agents; and Kipres, a leukotriene receptor antagonist anti-bronchial asthma and allergic rhinitis drug. It also provides Mucodyne, a mucoregulating drug; Montelukast KM, a drug for the treatment of bronchial asthma and allergic rhinitis; GeneSoC, a real-time PCR system; Rubysta, a disinfectant cleaner; Milton, a disinfectant; over-the-counter drugs; prescription medicines and quasi-drugs, diagnostics, and industrial chemicals; and reagents, intermediates, and other products. In addition, the company offers subcontracted drug manufacturing services. Further, it is involved in the discovery and evaluation of candidate compounds; and research and analysis of other companies’ technologies and collection of information concerning clinical trial. It has development and commercialization agreement with Hyfe Inc. for digital therapeutics (DTx) for chronic cough. The company was formerly known as KYORIN Holdings, Inc. KYORIN Pharmaceutical Co., Ltd. was founded in 1923 and is headquartered in Tokyo, Japan.

Employees
2042
Market
Japan

Compare 4569 to Peers and Sector

Metrics to compare
4569
Peers
Sector
Relationship
P/E Ratio
23.8x11.9x−0.5x
PEG Ratio
−2.420.090.00
Price/Book
0.7x1.1x2.6x
Price / LTM Sales
0.8x1.6x3.0x
Upside (Analyst Target)
−18.5%17.8%53.8%
Fair Value Upside
Unlock20.5%9.2%Unlock

Analyst Ratings

0 Buy
0 Hold
1 Sell
Ratings:
1 analysts
Overall Consensus
Sell

Analysts 12-Month Price Target:

Average 1,300.0
(-18.55% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 66.96%
Dividend Yield
3.26%
Industry Median 2.29%
Annualised payout
52.00
Paid unevenly
5-Years Growth
-7.06%
Growth Streak

Earnings

Latest Release
Feb 05, 2025
EPS / Forecast
20.60 / --
Revenue / Forecast
34.15B / --
EPS Revisions
Last 90 days

FAQ

What Is the Kyorin Holdings Inc (4569) Stock Price Today?

The Kyorin Holdings Inc stock price today is 1,596.00

What Stock Exchange Does Kyorin Holdings Inc Trade On?

Kyorin Holdings Inc is listed and trades on the Tokyo stock exchange.

What Is the Stock Symbol for Kyorin Holdings Inc?

The stock symbol for Kyorin Holdings Inc is "4569."

Does Kyorin Holdings Inc Pay Dividends? What’s The Current Dividend Yield?

The Kyorin Holdings Inc dividend yield is 3.26%.

What Is the Kyorin Holdings Inc Market Cap?

As of today, Kyorin Holdings Inc market cap is 91.69B.

What is Kyorin Holdings Inc Earnings Per Share?

The Kyorin Holdings Inc EPS is 66.96.

What Is the Next Kyorin Holdings Inc Earnings Date?

Kyorin Holdings Inc will release its next earnings report on 07 May 2025.

From a Technical Analysis Perspective, Is 4569 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.